Adoptive T-cell therapy after allogeneic hematopoietic stem cell transplantation (HCT) holds promise for amplifying the graft-versus-leukemia/tumor effect without graft-versus-host disease (GVHD).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback